Skip to main content
. 2020 Jun 29;8:23. doi: 10.1186/s40364-020-00202-7

Fig. 1.

Fig. 1

DNA damage response regulates tumor immunity. Defects in DNA damage response can result in both immunostimulation and immunosuppression. Production of neoantigens and/or activation of the cGAS/STING pathway can initiate anti-tumor immunity